Gross, Oliver <br/><br/>
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.  [electronic resource] 

 -  Kidney international  Mar 2012 
 - 494-501 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1038/ki.2011.407  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Angiotensin-Converting Enzyme Inhibitors--adverse effects<br/>Child<br/>Child, Preschool<br/>Disease Progression<br/>Endpoint Determination<br/>Female<br/>Humans<br/>Infant<br/>Kaplan-Meier Estimate<br/>Kidney--physiopathology<br/>Life Expectancy<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Nephritis, Hereditary--drug therapy<br/>Renal Insufficiency--mortality<br/>Renal Replacement Therapy<br/>Retrospective Studies<br/>Survival Rate<br/>Treatment Outcome<br/>Young Adult